Overview A Study to Evaluate the Efficacy and Safety of ANB019 in the Treatment of Subjects With Ichthyosis Status: Recruiting Trial end date: 2023-02-01 Target enrollment: Participant gender: Summary Efficacy and Safety of ANB019 in Subjects with Ichthyosis Phase: Phase 2 Details Lead Sponsor: AnaptysBio, Inc.